BD HPV Assay Receives WHO Prequalification for Global Cervical Cancer Screening
The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.
Category: Cervical (HPV)
Cervical (HPV)
Latest
Cervical (HPV)
Latest
Naveris Expands Availability of Test in Anal Cancer MRD Surveillance
Naveris expanded the commercial availability of its NavDx test, a non-invasive tool for detecting MRD in HPV-positive anal cancer patients.
Cervical (HPV)
Latest
Artificial Intelligence Is Transforming Pap Test Screening
Labcorp's adoption of artificial intelligence technology aims to enhance the screening process for cervical cancer.
HPV Self-Collection Is Recommended by Health Care Providers
A new study highlights support among healthcare providers for HPV self-collection, which could improve access to cervical cancer screening.
Read More
New Test Detects More Cases of Cervical Cancer
Researchers developed an effective cervical cancer screening method, which detects more cancers and precancerous stages than current methods.
Read More
U.S. Women Can Now Collect Their Own Cervical Cancer Screening Samples
BD received FDA approval for women to self-collect vaginal specimens for HPV testing, expanding access to cervical cancer screening.
Read More
Roche Announces FDA Approval of HPV Self-Collection Solution
che received FDA approval for its HPV self-collection solution, allowing individuals to collect their own samples.
Read More
At-Home Cervical Cancer Screening Device Gets FDA Breakthrough Designation
An at-home cervical cancer screening device received Breakthrough Device status to help increase testing access for people in need.
Read More
Researchers Discover Urine-Based Test to Detect Head and Neck Cancer
Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read More
Rural-Urban Disparities in Cervical Cancer Screening
The research highlighted factors influencing cervical cancer screening and highlighted the need for interventions to increase screening.
Read More
CMS Designates HPV Blood Test as an Advanced Diagnostic Lab Test
The TTMV-HPV DNA blood test provides a non-invasive method for detecting HPV-driven cancers before there is clinical evidence of disease.
Read More
ASCCP Cervical Cancer Management Guidelines Support Dual-Stain Triage Testing
The ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Read More
New Initiative Aims to Advance HPV-Driven Cancer Test
Naveris Launched an initiative aimed to expand the applications of its circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test.
Read More
BD and Camtech Health Partner to Improve Cervical Cancer Screening Access in Singapore
BD partnered with Camtech Health to advance cervical cancer screening by offering women in Singapore the option to self-collect a sample.
Read More
Cervical Cancer Screening: Survey Points to Self-Collection as Improving Access
In BD’s newest global survey, women reported self-collection would motivate them to have regular cervical cancer screening.
Read More
How Liquid Biopsy of Lymph Fluid Could Guide Head and Neck Cancer Treatment
Researchers discovered that lymphatic fluid from surgical drains could inform precise treatments for patients with head and neck cancer.
Read More
Roche Expands HPV Testing for Cobas 5800 Molecular System
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read More
FDA Approves Abbott HPV Test for Molecular PCR Platform
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read More